The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection

Research output: Contribution to journalReviewResearchpeer-review

Standard

The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection. / Apol, Ása Didriksen; Winckelmann, Anni Assing; Duus, Rasmus Bülow; Bukh, Jens; Weis, Nina.

In: Viruses, Vol. 15, No. 5, 1141, 2023.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Apol, ÁD, Winckelmann, AA, Duus, RB, Bukh, J & Weis, N 2023, 'The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection', Viruses, vol. 15, no. 5, 1141. https://doi.org/10.3390/v15051141

APA

Apol, Á. D., Winckelmann, A. A., Duus, R. B., Bukh, J., & Weis, N. (2023). The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection. Viruses, 15(5), [1141]. https://doi.org/10.3390/v15051141

Vancouver

Apol ÁD, Winckelmann AA, Duus RB, Bukh J, Weis N. The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection. Viruses. 2023;15(5). 1141. https://doi.org/10.3390/v15051141

Author

Apol, Ása Didriksen ; Winckelmann, Anni Assing ; Duus, Rasmus Bülow ; Bukh, Jens ; Weis, Nina. / The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection. In: Viruses. 2023 ; Vol. 15, No. 5.

Bibtex

@article{1bcc9a95696b415baf5ab5d5cd349f8d,
title = "The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection",
abstract = "Patients with chronic hepatitis B (CHB) gradually develop T cell exhaustion, and the inhibitory receptor molecule, cytotoxic T-lymphocyte antigen-4 (CTLA-4), may play a role in this phenomenon. This systematic review investigates the role of CTLA-4 in the development of T cell exhaustion in CHB. A systematic literature search was conducted on PubMed and Embase on 31 March 2023 to identify relevant studies. Fifteen studies were included in this review. A majority of the studies investigating CD8+ T cells demonstrated increased expression of CTLA-4 in CHB patients, though one study found this only in HBeAg-positive patients. Three out of four studies investigating the expression of CTLA-4 on CD4+ T cells found upregulation of CTLA-4. Several studies showed constitutive expression of CLTA-4 on CD4+ regulatory T cells. CTLA-4 blockade resulted in heterogeneous responses for all T cell types, as it resulted in increased T cell proliferation and/or cytokine production in some studies, while other studies found this only when combining blockade of CTLA-4 with other inhibitory receptors. Although mounting evidence supports a role of CTLA-4 in T cell exhaustion, there is still insufficient documentation to describe the expression and exact role of CTLA-4 in T cell exhaustion in CHB.",
keywords = "chronic hepatitis B, CTLA-4, immune checkpoint inhibitors, T cell exhaustion",
author = "Apol, {{\'A}sa Didriksen} and Winckelmann, {Anni Assing} and Duus, {Rasmus B{\"u}low} and Jens Bukh and Nina Weis",
note = "Publisher Copyright: {\textcopyright} 2023 by the authors.",
year = "2023",
doi = "10.3390/v15051141",
language = "English",
volume = "15",
journal = "Viruses",
issn = "1999-4915",
publisher = "M D P I AG",
number = "5",

}

RIS

TY - JOUR

T1 - The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection

AU - Apol, Ása Didriksen

AU - Winckelmann, Anni Assing

AU - Duus, Rasmus Bülow

AU - Bukh, Jens

AU - Weis, Nina

N1 - Publisher Copyright: © 2023 by the authors.

PY - 2023

Y1 - 2023

N2 - Patients with chronic hepatitis B (CHB) gradually develop T cell exhaustion, and the inhibitory receptor molecule, cytotoxic T-lymphocyte antigen-4 (CTLA-4), may play a role in this phenomenon. This systematic review investigates the role of CTLA-4 in the development of T cell exhaustion in CHB. A systematic literature search was conducted on PubMed and Embase on 31 March 2023 to identify relevant studies. Fifteen studies were included in this review. A majority of the studies investigating CD8+ T cells demonstrated increased expression of CTLA-4 in CHB patients, though one study found this only in HBeAg-positive patients. Three out of four studies investigating the expression of CTLA-4 on CD4+ T cells found upregulation of CTLA-4. Several studies showed constitutive expression of CLTA-4 on CD4+ regulatory T cells. CTLA-4 blockade resulted in heterogeneous responses for all T cell types, as it resulted in increased T cell proliferation and/or cytokine production in some studies, while other studies found this only when combining blockade of CTLA-4 with other inhibitory receptors. Although mounting evidence supports a role of CTLA-4 in T cell exhaustion, there is still insufficient documentation to describe the expression and exact role of CTLA-4 in T cell exhaustion in CHB.

AB - Patients with chronic hepatitis B (CHB) gradually develop T cell exhaustion, and the inhibitory receptor molecule, cytotoxic T-lymphocyte antigen-4 (CTLA-4), may play a role in this phenomenon. This systematic review investigates the role of CTLA-4 in the development of T cell exhaustion in CHB. A systematic literature search was conducted on PubMed and Embase on 31 March 2023 to identify relevant studies. Fifteen studies were included in this review. A majority of the studies investigating CD8+ T cells demonstrated increased expression of CTLA-4 in CHB patients, though one study found this only in HBeAg-positive patients. Three out of four studies investigating the expression of CTLA-4 on CD4+ T cells found upregulation of CTLA-4. Several studies showed constitutive expression of CLTA-4 on CD4+ regulatory T cells. CTLA-4 blockade resulted in heterogeneous responses for all T cell types, as it resulted in increased T cell proliferation and/or cytokine production in some studies, while other studies found this only when combining blockade of CTLA-4 with other inhibitory receptors. Although mounting evidence supports a role of CTLA-4 in T cell exhaustion, there is still insufficient documentation to describe the expression and exact role of CTLA-4 in T cell exhaustion in CHB.

KW - chronic hepatitis B

KW - CTLA-4

KW - immune checkpoint inhibitors

KW - T cell exhaustion

U2 - 10.3390/v15051141

DO - 10.3390/v15051141

M3 - Review

C2 - 37243227

AN - SCOPUS:85160638157

VL - 15

JO - Viruses

JF - Viruses

SN - 1999-4915

IS - 5

M1 - 1141

ER -

ID: 356559065